
Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …

The Anglo-Swedish drug maker AstraZeneca has joined Pfizer and others in halting price hikes until the end of 2018. AstraZeneca …

An experimental drug developed by the Massachusetts-based multinational Biogen and their Japanese partner Eisai has been shown to significantly slow …

Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines …

The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …

The government has announced that boys in England aged 12 and 13 will be vaccinated against Human Papilloma Virus (HPV) …

Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that …

Figures have revealed a trend towards an increased number of prescriptions for antidepressants for children in England, Scotland, and Northern …

A trial of the drug sildenafil, commonly sold under the brand name Viagra, has been halted immediately after the death …

Israeli multinational Teva Pharmaceuticals have announced the appointment of Stana Moisescu as the General Director of Teva Romania, the company’s …

Bristol Myers Squibb has announced that Executive Vice President and Chief Commercial Officer, Murdo Gordon, who has been with the …

Celgene has lifted the curtain on new Phase 3 data for its combo of Revlimid (lenalidomide) plus rituximab (R2) in …

Employees of the British multinational GlaxoSmithKline (GSK) have led a protest against the shutting down of manufacturing facilities in Bangladesh. …

A team of scientists, led by Professor Laura Piddock from the University of Birmingham, have launched a free, open access, …

AstraZeneca has announced its intention to hand over the European commercial rights to its heart failure and blood pressure treatment …

The FDA has approved GSK’s Krintafel for the treatment of a recurring form of malaria in patients aged 16 and …

Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …

The oral leukaemia treatment Tibsovo (ivosidenib) produced by Massachusetts-based Agios Pharmaceuticals has been approved for treatment of adult patients with …

The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …

Swiss multinational Roche has joined Pfizer and others in halting price hikes. However critics have condemned the move as observers …